Gilead Sciences, Inc. (NASDAQ:GILD) is a biotech company that advances medicines to prevent and treat serious diseases such ...
Gilead Sciences, Inc. (NASDAQ:GILD) is a biotech company that advances medicines to prevent and treat serious diseases such as cancer, immunodeficiency virus (HIV), viral hepatitis, and COVID-19. Its ...
Upbeat phase III findings outweighed less encouraging late-stage trial news, as big pharma provided a mixed bag of cancer findings – with one data batch to form... Structure Therapeutics Inc.’s stock ...
F2G’s hopes of getting the first in a brand-new class of antifungals to market have hit a setback courtesy of a complete response letter from the FDA. The regulator was due to make a call on approving ...
F2G Ltd. today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for olorofim, an investigational antifungal, ...
Please read this document carefully before you start to take your medicine, even if you have taken this medicine before. The medicine your doctor has prescribed for you is called AmBisome® for ...
The World Health Organization (WHO) and Gilead Sciences have signed a new agreement for the donation of 304,700 vials of AmBisome (liposomal amphotericin B for injection), for the treatment of ...
Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has obtained the Food and Drug Administration’s clearance for amphotericin B liposome for injection, 50 mg /vial, which is a generic of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results